Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710380 · ClinicalTrials.gov registry record · NA
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
A NA study of Prostate Cancer and Prostate Adenocarcinoma, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05710380 is a NA study of Prostate Cancer and Prostate Adenocarcinoma that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 180 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05710380, a NA study of Prostate Cancer and Prostate Adenocarcinoma, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this research will last about 12 months. There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.
Conditions Studied
Interventions
- OTHER Risk Map Decision Support System (DSS).
- RADIATION Magnetic Resonance Imaging (MRI)
- PROCEDURE Magnetic Resonance Imaging (MRI) Guided Biopsy
Study Locations (1)
Illinois
- University of Chicago Medicine Comprehensive Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05710380
The ClinicalTrials.gov registry entry for NCT05710380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (70% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Risk Map Decision Support System (DSS). is the first listed.
NCT05710380 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05710380 about?
NCT05710380 is a clinical study titled "MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy". Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this re...
What is the current status of trial NCT05710380?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-04-26. Estimated completion is 2026-05-01.
What conditions does trial NCT05710380 study?
This clinical trial studies the following conditions: Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm.
What interventions are being tested in trial NCT05710380?
The interventions under investigation include: Risk Map Decision Support System (DSS). (OTHER), Magnetic Resonance Imaging (MRI) (RADIATION), Magnetic Resonance Imaging (MRI) Guided Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05710380?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710380 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.